, Tracking Stock Market Picks
Enter Symbol:
Geron Corporation (GERN) [hlAlert]

Mkt Outperform
down 56.55 %

Geron Corporation (GERN) rated Mkt Outperform with price target $9 by Rodman & Renshaw

Posted on: Friday,  Jan 23, 2009  9:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Geron Corporation (NASDAQ: GERN) on 01/23/2009, when the stock price was $7.09.
Since then, Geron Corporation has lost 56.56% as of 01/25/2016's recent price of $3.08.
If you would have followed this Rodman & Renshaw's recommendation on GERN, you would have lost 56.55% of your investment in 2558 days.

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/23/2009 9:25 AM Buy
7.09 9.00
as of 12/31/2009
1 Week down  -18.21 %
1 Month down  -8.28 %
3 Months down  -27.43 %
1 YTD down  -32.86 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy